# Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

> **NCT01929213** · PHASE1 · UNKNOWN · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Udenafil
- **DRUG:** Bosentan
- **DRUG:** Udenafil/Bosentan

## Key facts

- **NCT ID:** NCT01929213
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2013-11
- **Final completion:** 2014-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929213, "Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01929213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*